← Back to Patent Explorer
US5296514A Expired / Lapsed US ⏱️ 0.0 years remaining

Corneal treatment agents

Assignee: Avanir Pharmaceuticals Inc
•
Filing: 1993-05-21
•
Granted: 1994-03-22
•
Expires: 2013-05-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Aliphatic alcohols are disclosed for promoting corneal healing following injury to the eye. Such compositions ameliorate corneal discomfort, alleviate visual artifacts, and/or reduce irritation caused by the eye injury. The compositions also promote the regrowth of epithelial tissue over the corneal surface.

Inventors

  • 👤 David F. Muller

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 07:01
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/045

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 44 words
A method of promoting corneal healing following injury to an eye comprising: applying topically to the cornea of an injured eye, an aliphatic alcohol having a chain length ranging from about C-20 to about C-26 and in an amount effective to promote corneal healing.
Claim 2
Independent Claim 44 words
A method of promoting corneal healing following injury to an eye comprising: applying topically to the cornea of an injured eye, an aliphatic alcohol having a chain length ranging from about C-20 to about C-26 and in an amount effective to promote corneal healing.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein the aliphatic alcohol is docosanol.
Claim 4
Dependent Claim 11 words
The method of claim 1 wherein the aliphatic alcohol is tetracosanol.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein the aliphatic alcohol is hexacosanol.
Claim 6
Dependent Claim 31 words
The method of claim 1 wherein the aliphatic alcohol is applied in a concentration ranging from about 0.2 to about 30% by weight in a physiologically compatible carrier to the cornea.
Claim 7
Dependent Claim 31 words
The method of claim 1 wherein the aliphatic alcohol is applied in a concentration ranging from about 1 to about 5% by weight in a physiologically compatible carrier to the cornea.

References Cited (Backward Citations)

US3584115A Cited
DE2358662A1 Cited
GB1393850A Cited
EP0127468A2 Cited
US4738956A Cited
US4939135A Cited
US4874794A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-03-21 1997-09-20 1998-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-03-21 2001-09-20 2002-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-03-21 2005-09-20 2006-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag